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Circumdatin H (1), a new alkaloid from the culture broth of Aspergillus ochraceus, has been 
isolated, together with a known circumdatin, circumdatin E (2) and other known compounds: 
flavacol (3) and stephacidin A (4). The structure of 1 was established in the basis of chemical and 
spectral evidence. All of these alkaloids showed biological activity as inhibitors of the mammalian 
mitochondrial respiratory chain.  
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Many natural products from Aspergillus ochraceus extracts show very interesting biological 
activities, such antitumor activity1-3) (e.g. avrainvillamide and stephacidin A and B) and antifungal4), 
insecticide5) and antibiotic6) activities. Recently, a new group of benzodiazepines, circumdatins A-G, 
has been isolated from this fungus7-9). This group is considered a good chemotaxonomic marker to A. 
ochraceus fungus (Aspergillus subgenus Circumdati, section Circumdati, formerly the A. ochraceus 
group). 
In the search of biologically active metabolites, an extract of A. ochraceus culture broth was 
studied. In this manuscript the isolation from this extract of a new circumdatin (1), with other three 
known alkaloids (2-4)2,8,10,11), is reported. All of these alkaloids were assayed as inhibitors of 
integrated electron transfer chain, due to their structural analogies with well-known inhibitors of the 
respiratory chain12,13). 
 
Materials and Methods/ Experimental  
 
General Experimental Procedures 
Optical rotation was measured with a Jasco P-1030 polarimeter. IR spectra were obtained with a 
Nicolet 710FT spectrophotometer. UV spectrum was obtained using a Shimadzu UV-210PC 
spectrophotometer. Mass spectra were performed with a VG Auto Spec Fisons spectrometer. 1H, 13C 
and COSY H-H NMR spectra were recorded on a Bruker 300 MHz. Multiplicities of 13C NMR were 
determined by DEPT experiments. For the HSQC and HMBC NMR experiments a Bruker 600 
spectrometer was used. TLC was run on Silica gel F254 precoated plates (Merck 5554) and spots 
were detected by UV light. Isolation of alkaloids 1-4 was carried by a Waters HPLC system, with a 
600 pump and a 2996 Photodiode Array Detector.  
 
Taxonomic of Producers 
The fungus was isolated from infected soil in our laboratory and was classified by the 
Centralbureau voor Schimmelcultures (CBS, Utrecht, The Netherlands) as Aspergillus ochraceus 
Wilhelm. A sample of this strain is deposited in the “Cátedra de Ecología Química Agrícola” of the 
Universidad Politécnica de Valencia. It is coded as HG10 and kept in agar slants with potato 
dextrose agar (PDA) as culture medium.  
 
Fermentation 
The strain was seeded in Petri dishes with PDA culture medium and incubated for 7 days at 28 ºC. 
Then, a solution of Tween 80 (0.05%) in sterile distilled water was used to obtain a suspension 
containing ca. 106 conidia/ mL. This suspension (100 mL) was added to a 5 L Erlenmeyer flask with 
1 L of antibiotic test broth (composition: yeast extract, 2.0 g; bacto peptone, 3.0 g; glucose, 2.0 g; 
sucrose, 30.0 g; corn steep, 5.0 g; NaNO3, 2.0 g; K2HPO4·3H2O, 1.0 g; MgSO4·7H2O, 0.5 g; KCl, 
0.2 g; FeSO4·7H2O, 0.01 g; distilled water, 1000 mL; pH 7) and was incubated for 22 days, in the 
dark, with shaking (200 rpm), at 25 ºC. 
 
Isolation/ Purification 
After incubation, the mycelium was removed from the culture broth by filtration. Then the broth 
(30 L) was partially evaporated in vacuum to 1 L and was extracted with CH2Cl2/EtOAc 1:1 (3 x 1 
L). The CH2Cl2/EtOAc 1:1 extract was dried under reduced pressure to obtain a brown solid (5.2 g). 
This resulting organic extract was partitioned by flash column chromatography on Silica gel (1:100, 
w/w) using stepwise gradient from CH2Cl2 to MeOH (CH2Cl2; CH2Cl2/EtOAc 70/30; CH2Cl2/EtOAc 
50/50; CH2Cl2/EtOAc 20/80; EtOAc; EtOAc/MeOH 96/4; EtOAc/MeOH 8/2; MeOH). 1 L of each 
mobile phase was eluted and eight fractions were collected.  
The fourth fraction (130 mg) was subjected to flash column chromatography on Silica gel (1:100, 
w/w) using as mobile phase CH2Cl2/MeOH 98:2. This mixture was eluted and collected in aliquots 
of 3 mL, which were pooled in ten subfractions according to their similarity by TLC. Subfractions 4 
(SF-4) and 5 (SF-5) were analyzed by HPLC. Semipreparative HPLC of SF-4 (18.3 mg) was 
performed using the following conditions: Spherisorb ODS2 C18 column, 5 µm (25.0 x 0.7 cm); 
mobile phase MeOH/H2O (70/30, v/v); flow, 1 mL/min; detection by Photodiode Array. Two pure 
products were obtained from SF-4: (1) [retention time (Rt)=19.89 min; 1.2 mg] and (2) [Rt=11.45 
min; 2.5 mg]. Semipreparative HPLC of SF-5 (5.8 mg) was performed using the following 
conditions: Spherisorb ODS2 C18 column, 5 µm (25.0 x 0.7 cm); mobile phase MeOH/H2O (70/30, 
v/v); flow, 1 mL/min; detection by Photodiode Array. One pure product was obtained from SF-5: (3) 
[Rt= 14.53 min; 5.0 mg].  
The fifth initial fraction (132 mg) was subjected to flash column chromatography on Silica gel 
(1:100, w/w) using as mobile phase CH2Cl2/MeOH 96:4. This mixture was eluted and collected in 
aliquots of 3 mL, which were pooled in eleven subfractions according to their similarity by TLC. 
Subfraction 6 (SF-6) was analyzed by HPLC. Semipreparative HPLC of SF-6 (21.2 mg) was 
performed using the following conditions: Spherisorb ODS2 C18 column, 5 µm (25.0 x 0.7 cm); 
mobile phase MeOH/H2O (70/30, v/v); flow, 1 mL/min; detection by Photodiode Array. One pure 
product was obtained from SF-6: (4) [Rt=13.62 min; 15.7 mg].  
 
Physico-chemical Properties 
Circumdatin H (1) was obtained as a colorless amorphous substance. HREIMS m/z 347.1364 
(M+) (calcd for C20H17N3O3, 347.1269). UV (MeOH) λmax (log ε) 329 (3.08), 276 (2.61), 230 (2.04) 
nm; IR (film) νmax 2929, 1685, 1644, 1618, 1495, 1449, 1367, 1239 cm-1. [α]D –26.3º (c 0.078, 
MeOH). 1H (300 MHz, CDCl3) and 13C (75 MHz, CDCl3) NMR data (see Table 1). 
Compound 2 was identified as circumdatin E by comparison of its spectral data with the 
literature8). All data of compound 3 were coincident with flavacol10,11). Compound 4 was identified 
as stephacidin A by comparison of its spectral data with the literature2). 
 
Biological Assays 
The inhibitory activity of alkaloids 1-4 was assayed by using submitochondrial particles (SMP) 
from beef heart, according to Estornell et al. and Fato et al.14,15). Stock solutions (15 mM in absolute 
EtOH) of 1-4 were prepared and kept in the dark at –20 ºC. Each compound was added to the diluted 
SMP preparation and incubated, during 5 min, in ice. NADH oxidase activity was measured 
according to Fontana et al.16). For each compound, three experiments were carried out. 
 
Results and Discussion 
 
The isolation and structure characterization of a novel benzodiazepine, circumdatin H (1), as 
minor constituent of A. ochraceus culture broth is reported, together the known benzodiazepine 
circumdatin E (2)8), the pyrazinone flavacol (3)10,11) and the alkaloid stephacidin A (4)2). 
The structure of 1 was determined by comparison of its 1H NMR and 13C NMR spectral data 
(Table 1) with those of other known circumdatins, especially 2, and was confirmed by 2D NMR 
experiments (COSY H-H, HSQC and HMBC)7,9). According to the spectral data of 1, this compound 
presented a benzodiapezine structure derived from proline and anthranilic acid joined to an other 
anthranilic acid unit, as in 2 and circumdatin D (5). 
A molecular formula of C20H17N3O3 for 1, determined by HREIMS, indicated that 1 had one less 
oxygen atom compared with 2. Examination of the 1H, COSY and HMBC spectra of 1 indicated the 
presence of three aromatic protons in ring D (δ 7.68 d, J= 2.9 Hz; 7.65 d, J= 8.9 Hz; 7.38 dd, J= 8.9, 
2.9 Hz) in place of the two aromatic protons in D ring of 2. Also, 1 presented a D ring methoxy 
group at C-13 as in 2, according to long-range 1H-13C correlations (from C-13 to -OCH3-23 and H-
15; from C-16 to H-14; and from C-14 to H-12) observed in the HMBC spectrum of 1, and 
according to the NOE correlation between -OCH3-23 and H-12. Thus, the only difference between 1 
and 2 was the substitution of the D ring hydroxy group in 2 with a proton in 1. The stereochemistry 
at C-19 of 1 was tentatively assigned by comparison of the sign of the optical rotation value of 1 (-
26.3 º) with that of other circumdatins.  
The structural resemblance of the quinazolinone moiety of these alkaloids with some moieties of 
the well-known inhibitors of the mitochondrial respiratory chain such fenazaquin, prompted us to the 
evaluation of 1 and 2 as inhibitors of this process12,13). Alkaloids 1 and 2 were found to be inhibitors 
of the integrated electron transfer chain (NADH oxidase activity) with IC50 values of 1.5 ± 0.1 and 
2.5 ± 0.3 µM, respectively. Alkaloids 1 and 2 were placed in a middle range with respect to the most 
potent complex I respiratory inhibitors, such rotenone, with an IC50 of 4.4 nM17). Alkaloid 1 was 
more slightly active than 2; therefore it seems possible that the hydroxy group at C-15 of 2 makes 
the interaction with the respiratory chain more difficult.  
Flavacol (3) and stephacidin A (4) also were assayed as mitochondrial respiratory inhibitors, 
because they present a relative structural similarity with other known inhibitors such rotenone or 
fenazaquin12,13). Compounds 3 and 4 were able to inhibit this respiratory chain with IC50 values 
between five and twenty-five times higher than 1 and 2 (Table 2). The slight inhibitory potency of 4 
could demonstrate that the mitochondrial chain inhibition is not the mechanism of action that 
explains the antitumor activity of this compound2,3). 
Circumdatins show a range of inhibitory activity similar to other interesting inhibitors of the 
mammalian mitochondrial respiratory chain, such stolonoxides16). As others respiratory chain 
inhibitors specially of the complex I type, the more active compounds 1 and 2 may serve as lead for 
the development of news tools for insect control based in this mechanism of action and also for basic 
biomedical research12,13,17,18) Thus, detailed comparisons of the inhibitory action of structurally 
different inhibitors will allow to understand more deeply the mechanism of redox-driven proton 
pumping of respiratory chain, whose defects are associated with mitochondrial degeneration diseases 
as Parkinson’s and Huntington’s diseases18). 
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Table 1. 1H and 13C NMR Data of circumdatin H (CDCl3, 300 MHz and 75 MHz, respectively). 
 
 δH (m,a J in Hz) δC HMBC 
with H 
2 - 165.1 8.00 
3 - 133.1 7.57, 8.00 
4 8.00 (dd, 7.2, 1.1) 130.3 - 
5 7.55 (m) 129.0 - 
6 7.57 (m) 131.1 7.55 
7 7.57 (m) 128.8 8.00 
8 - 124.2 - 
10 - 162.5 - 
11 - 134.2 - 
12 7.68 (d, 2.9) 107.3 - 
13 - 159.0 7.65, 3.93 
14 7.38 (dd, 8.9, 2.9) 125.3 7.68 
15 7.65 (d, 8.9) 129.6 - 
16 - 141.7 7.38 
18 - 153.7 4.54, 2.18 





















Table 2. Inhibitory potency of compounds 1-4 against NADH oxidase. 
 
Inhibitors IC50 (µM) 
1 1.5 ± 0.1 
2 2.5 ± 0.3 
3 13.0 ± 0.4  
4 34.6 ± 2.2  
 
